## Abstract Drugβeluting stents (DES) seemed likely to mitigate the problem of restenosis and have become the predominant stent deployed during percutaneous coronary intervention (PCI). Sustained concerns about the rate of stent thrombosis (ST), particularly very late ST (>1 year following PCI) led
Food and Drug Administration centennial: Recognizing the guardians of our drug supply
β Scribed by John F. Beary
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 31 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
of them cause a response in the inicrobiological Rahway, N. J. assay. Thus a method that cuuld differentiate Kesearch, New Brunswick, N. J. between the biologically-active cobalamins and \* Received ~~~~~b~~ 6, 1956, from the Division of Nutrit Division of Nutrition, Food and Drug Administration,
A study has been made of the efficacy of several commercial mouthwashes representing as many classes of chemical agents. T h e method employed tends to represent, as closely as possible, the conditions of use. The selective antibacterial activity of the washes was measured in terms of "before" and "